Immunohistochemical expression of p16INK4a is predictive of HR-HPV infection in cervical low-grade lesions

Modern Pathology

Volumn 19, Issue 3, 2006, Pages 384-391

  Benevolo, Maria ^a   Mottolese, Marcella ^a   Marandino, Ferdinando ^a   Vocaturo, Giuseppe ^a   Sindico, Roberto ^a   Piperno, Giulia ^a   Mariani, Luciano ^a   Sperduti, Isabella ^a   Canalini, Paola ^a   Donnorso, Raffaele P ^a   Vocaturo, Amina ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cervical intraepithelial neoplasia; Human papillomavirus; p16INK4a; Progression risk

Indexed keywords

PROTEIN P16; RETINOBLASTOMA PROTEIN;

ARTICLE; CELL CYCLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PHOSPHORYLATION; PREDICTION; PRIORITY JOURNAL; PROTEIN TRANSPORT; UPREGULATION; UTERINE CERVIX; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CELL LINE, TUMOR; CERVIX UTERI; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; GENOTYPE; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 33244466951     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800551     Document Type: Article

References (32)

1. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-265.
2. Munoz N, Bosch FX, De Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527.
3. Daltein V, Riethmuller D, Pretet J-L, et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal french cohort study. Int J Cancer 2003;106:396-403.
4. Fehrmann F, Laimins LA. Human Papillomavirus: targeting differentiating epithelial cells for malignant transformation. Oncogene 2003;22:5201-5207.
5. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
6. Giarrè M, Caldeira S, Malanchi I, et al. Induction of Rb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle arrest. J Virol 2001;75:4705-4712.
7. INK4a are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001;25:884-891.
8. INK4a expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high risk HPV types. Mod Pathol 2003;16:665-673.
9. INK4a munoexpression and HPV in situ hybridation signal patterns. Am J Surg Pathol 2005;29:674-679.
10. INK4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-284.
11. Klaes R, Benner A, Friedrich T, et al. Immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002;26:1389-1399.
12. INK4a as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep™ smears. J Clin Pathol 2003;56:56-63.
13. INK4a CDC6 and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol 2005;58:525-534.
14. Sano T, Oyama T, Kashiwabara K, et al. Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol Int 1998;48:580-585.
15. Sano T, Oyama T, Kashiwabara K, et al. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998;153:1741-1748.
16. Sano T, Masuda N, Oyama T, et al. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int 2002;52:375-383.
17. INK4a and bcl-2 according to HPV type and to the progression of cervical squamous intraepithelial lesions. J Histochem Cytochem 2005;53:509-516.
18. Galen RS, Gambino SR. Beyond Normality: the Predictive Value and Efficiency of Medical Diagnoses. Wiley: New York, 1972.
19. Fleiss JL. Statistical Methods for Rates and Proportions. John Wiley & Sons: New York, 1981.
20. Stoler MH, Schiffman M. Atypical Squamous Cells of Undetermined Significance-Low grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001;285:1500-1505.
21. Wright TC, Kurman RJ, Ferenczy A. Precancerous lesions of the cervix. In: Kurman RJ (ed). Blaustein's Pathology of the Female Genital Tract, 4th edn. Inc. Springer-Verlag: New York, 1994, pp 229-277.
22. Wells M, Ostor AG, Crum CP, et al. Epithelial tumors. In: Tavassoli FA, Devilee P (eds) World Health Organization Classification of Tumors, Tumors of the Breast and Female Genital Organs. IARC Press: Lyon, 2003, pp 262-279.
23. von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 2002;38:2229-2242.
24. Esposito V, Baldi A, Tonini G, et al. Analysis of cell cycle regulator proteins in non-small cell lung cancer. J Clin Pathol 2004;57:58-63.
25. Ghiorzo P, Villaggio B, Sementa AR, et al. Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients. Hum Pathol 2004;35:25-33.
26. INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter metylation and poor prognosis. J Pathol 2003;201:487-495.
27. von Knebel Doeberitz M, Oltersdorf T, Schwarz E, et al. Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res 1988;48:3780-3786.
28. zur Hausen H. Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes. Semin Cancer Biol 1999;9:405-411.
29. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev 2002;2:342-350.
30. Xu R, Perle MA, Inghirami G, et al. Amplification of HER2/neu gene in HER2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant and metastatic lesions detected by FISH in archival material. Mod Pathol 2002;15:116-124.
31. Mottolese M, Nadasi EA, Botti C, et al. Phenotypic changes of p53, HER2, and FAS system in multiple normal tissues surronding breast cancer. J Cell Physiol 2005;204:106-112.
32. INK4a overexpression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri. Virchows Arch 2004;445:616-620.